<DOC>
	<DOCNO>NCT02585440</DOCNO>
	<brief_summary>This phase 1 study evaluate safety tolerability multiple oral dos CMX157 increase dose level .</brief_summary>
	<brief_title>A Multiple Dose Study Safety , Tolerability PK CMX157 Healthy Subjects</brief_title>
	<detailed_description>This phase 1 study evaluate safety tolerability multiple oral dos CMX157 increase dose level , fast state feed state .</detailed_description>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>Age : 1855 . Capable give write informed consent . Capable completing study requirement . Positive result HIV , HBV , HCV . History medical condition could impact patient safety . Current past abuse alcohol illicit drug . Participation another clinical trial within past 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>